COVID-19: FDA broadens EUA for remdesivir
by Press Release from Outbreak News Today on (#57FXW)
As part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration today broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to include treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19, irrespective of their severity of disease. In May 2020, the FDA [...]
The post COVID-19: FDA broadens EUA for remdesivir appeared first on Outbreak News Today.